Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEInvestor Presentation▲ PositiveResults30 Oct 2026

Privi Speciality Chemicals Limited

Investor Presentation

Privi Speciality Chemicals Limited has informed the Exchange about Investor Presentation for Q2 & H1 FY27 results, highlighting strong financial performance, resilience of business model, and disciplined execution.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults30 Oct 2026

Privi Speciality Chemicals Ltd

Investor Presentation - Financial & Operational Review for Quarter and half year ended September 30,2026.

Privi Speciality Chemicals Ltd has released its investor presentation for Q2 and H1 FY27, showcasing strong financial performance with a 13.9% year-on-year growth in total income, 16.66% year-on-year growth in EBITDA, and 24.61% year-on-year growth in Net Profit. The company attributes its resilience to its diversified geographic presence and disciplined execution despite adverse global headwinds.

Read more →📎 1 attachment
NSEUpdates▲ PositiveOrder Win30 Oct 2026

Acme Solar Holdings Limited

Updates

ACME Solar Holdings Limited has signed a Power Purchase Agreement (PPA) with NTPC Limited for a 400 MW Inter-State Transmission System (ISTS)-connected Firm and Dispatchable Renewable Energy (FDRE) project at a tariff of INR 4.37 per unit.

Read more →📎 1 attachment
BSECompany Update▲ PositiveExpansion30 Oct 2026

Lords Mark Industries Ltd

Regulation 30 intimation

Lords Mark Industries Ltd announces Regulation 30 intimation titled 'Brahamastra, Part Of Lord's Mark Industries Limited, Takes Indigenous Defence Innovation To The Global Stage'. The company is pursuing an ambitious vision to position India as a global force in indigenous defence technology, with a focus on advancing indigenous defence manufacturing in line with the Atmanirbhar Bharat initiative.

Read more →📎 1 attachment
NSEPress Release▲ PositiveExpansion30 Oct 2026

Hikal Limited

Press Release

Hikal Limited's Bengaluru API facility has been granted Swissmedic GMP certification, strengthening its global regulatory standing and expanding access to European and other regulated markets.

Read more →📎 1 attachment
NSEPress Release▲ PositiveExpansion30 Oct 2026

Sun Pharmaceutical Industries Limited

Press Release

Sun Pharmaceutical Industries Limited has announced that the U.S. FDA has approved ILUMYA (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis, expanding the use of ILUMYA beyond moderate-to-severe plaque psoriasis.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults30 Oct 2026

Fabtech Technologies Ltd

Please find attached Investor Presentation in relation to the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half- year ended September 30, 2026.

Fabtech Technologies Ltd has released its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, with revenue and EBITDA (including other income) doubling QoQ to ₹155.7 mn in Q2 FY27, and management confident of achieving its FY27 Adjusted PAT margin objective of 8-9%.

Read more →📎 1 attachment
BSECompany Update▲ PositiveExpansion30 Oct 2026

MTAR Technologies Ltd

Investor presentation

MTAR Technologies Ltd presented its investor presentation for October 2026, highlighting its focus on indigenising critical technologies, revenue growth of 80%, and EBITDA margin of 24% ±100 bps. The company aims to build a diversified and resilient business by expanding its product portfolio, increasing wallet share with existing customers, and growing its global customer base.

Read more →📎 1 attachment
NSEBagging/Receiving of orders/contracts▲ PositiveOrder Win29 Oct 2026

Tonbo Imaging India Limited

Bagging/Receiving of orders/contracts

Tonbo Imaging India Limited has received a strategic export order from a state-owned company in Europe for the supply of its EO/IR stabilised seeker, valued at approximately EUR 65,000, with an option to place an order for a total potential value of approximately EUR 13 million.

Read more →📎 1 attachment
NSEAgreements▲ PositiveM&A29 Oct 2026

Krishna Institute of Medical Sciences Limited

Agreements

Krishna Institute of Medical Sciences Limited has entered into definitive agreements to acquire a 51% equity stake in Sarvottam Health Care Private Limited for ₹80.00 crore, with the transfer of shares expected to be completed in due course.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults29 Oct 2026

Adani Total Gas Ltd

Transcript of Earning Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026

Adani Total Gas Ltd reported strong operational performance for the quarter and half year ended September 30, 2026, with Q2 FY '27 volumes growing 12% year-on-year to 315 MMSCM and EBITDA increasing 12% to INR340 crores. For half year ended 30th September 2026, volumes grew 13% to 618 MMSCM and EBITDA rose 3% to INR621 crores.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults29 Oct 2026

DCB Bank Limited

Analysts/Institutional Investor Meet/Con. Call Updates

DCB Bank Limited has announced its Q2 FY27 earnings, with net interest income growing by 17% Y-o-Y, advances growing by 21% Y-o-Y, and deposits growing by 19%. The bank's net profit has risen by 29% over the year to INR 236 crores, the highest ever in a quarter. The bank has also achieved a 7.23% improvement in PCR and a 9.6% improvement in PCR excluding technical write-off.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults29 Oct 2026

DCB Bank Ltd

Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the transcript of the Earnings Conference Call held on October 23, 2026 with respect to the Unaudited Financial Results of DCB Bank Limited ('the Bank') for the quarter and half year ended September 30, 2026. The same has also been uploaded on website of the Bank and can be accessed at the link given in the letter.

DCB Bank Ltd reported Q2FY27 results with 21% Y-o-Y growth in advances, 19% Y-o-Y growth in deposits, and 17% Y-o-Y growth in net interest income. Net profit rose by 29% over the year to INR 236 crores, the highest ever in a quarter. The bank's ROA and ROE were 1.03% and 14.6% respectively for the quarter, and 1% and 14.12% respectively for the half year.

Read more →📎 1 attachment
← PreviousPage 167 of 930Next →